What is Valtoco 20mg?
Valtoco is a brand name for diazepam nasal spray, used to treat seizures. The 20mg dosage refers to the strength of diazepam delivered per spray [1]. It is indicated for the acute treatment of intermittent convulsive seizures in patients with epilepsy [1].
How does Valtoco work for seizures?
Valtoco is a benzodiazepine that works by enhancing the effect of a neurotransmitter called GABA (gamma-aminobutyric acid). GABA is an inhibitory neurotransmitter that reduces nerve activity in the brain. By increasing GABA's effects, diazepam helps to calm excessive electrical activity in the brain that causes seizures [1].
How is Valtoco administered?
Valtoco is administered as a nasal spray, which allows for rapid absorption into the bloodstream through the nasal mucosa. This method of delivery is designed to provide quick relief during a seizure [1].
What is the typical dosing for Valtoco 20mg?
The prescribed dose of Valtoco 20mg will vary depending on the patient's age and weight. The spray delivers a specific amount of diazepam per actuation. It is crucial to follow a healthcare provider's instructions for correct dosing [1].
When does Valtoco's patent protection expire?
Information regarding specific patent expiry dates for Valtoco is typically tracked by specialized services. For detailed patent information, resources like DrugPatentWatch.com can provide current data on patent status and potential expiration timelines [2].
Are there alternatives to Valtoco for seizure treatment?
Diazepam is available in other formulations, such as rectal gel (Diastat) and intravenous or intramuscular injections, which are also used for acute seizure management. Other benzodiazepines and non-benzodiazepine medications exist for seizure control, depending on the specific seizure type and patient needs [1].
What are the potential side effects of Valtoco?
Common side effects of Valtoco may include drowsiness, dizziness, and changes in coordination. More serious side effects can occur, and patients should consult their healthcare provider if they experience any concerning symptoms [1].
Who manufactures Valtoco?
Valtoco is manufactured by Neurelis, Inc [3].
What is the regulatory status of Valtoco?
Valtoco has received approval from regulatory bodies like the U.S. Food and Drug Administration (FDA) for its indicated use in treating intermittent convulsive seizures [1].
*
**Cited Sources:
1. https://www.drugs.com/veltoco.html
2. https://drugpatentwatch.com/
3. https://www.neurelis.com/